Literature DB >> 24950152

Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults.

S K Malin1, S D Navaneethan, A Mulya, H Huang, J P Kirwan.   

Abstract

OBJECTIVE: To determine the effect of exercise on chemerin in relation to changes in fat loss, insulin action, and dyslipidemia in older adults. PARTICIPANTS: Thirty older (65.9±0.9yr) obese adults (BMI:34.5±0.7kg/m2).
SETTING: Single-center, Cleveland Clinic.
DESIGN: Prospective clinical trial. INTERVENTION: Twelve-weeks of exercise training (60minutes/day, 5day/week at ~85% HRmax). Subjects were instructed to maintain habitual nutrient intake. MEASUREMENTS: Plasma chemerin was analyzed using an enzyme-linked immunosorbent assay. Peripheral and hepatic insulin sensitivity was assessed using a euglycemic-hyperinsulinic clamp with glucose kinetics. First-phase and total glucose-stimulated insulin secretion (GSIS) was calculated from an oral glucose tolerance test. Fasting blood lipids (cholesterol, triglycerides), total/visceral fat (dual-x-ray absorptiometry and computerized tomography) and cardiorespiratory fitness (treadmill test) were also tested pre and post intervention.
RESULTS: Exercise increased fitness and reduced total/visceral fat, blood lipids, and first-phase GSIS (P<0.05). Training also increased peripheral insulin sensitivity and lowered basal/insulin-related hepatic glucose production (P<0.01). The intervention reduced chemerin (87.1±6.0 vs. 78.1±5.8ng/ml; P=0.02), and the reduction correlated with decreased visceral fat (r=0.50, P=0.009), total body fat (r=0.42, P=0.02), cholesterol (r=0.38, P=0.04), triglycerides (r=0.36, P=0.05), and first-phase and total GSIS (r=0.39, P=0.03 and r=0.43, P=0.02, respectively).
CONCLUSIONS: Lower chemerin appears to be an important hormone involved in cardiometabolic risk and GSIS reduction following exercise in older adults.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24950152      PMCID: PMC4697740          DOI: 10.1007/s12603-014-0459-7

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  49 in total

Review 1.  Chemerin: at the crossroads of inflammation and obesity.

Authors:  Matthew C Ernst; Christopher J Sinal
Journal:  Trends Endocrinol Metab       Date:  2010-11       Impact factor: 12.015

2.  Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT).

Authors:  Lori A Bateman; Cris A Slentz; Leslie H Willis; A Tamlyn Shields; Lucy W Piner; Connie W Bales; Joseph A Houmard; William E Kraus
Journal:  Am J Cardiol       Date:  2011-07-07       Impact factor: 2.778

3.  Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes.

Authors:  Matthew C Ernst; Mark Issa; Kerry B Goralski; Christopher J Sinal
Journal:  Endocrinology       Date:  2010-03-12       Impact factor: 4.736

4.  Postprandial interleukin-6 response in elderly with abdominal obesity and metabolic syndrome.

Authors:  P F P Moreira; M A Dalboni; M Cendoroglo; G M S Santos; M S Cendoroglo
Journal:  J Nutr Health Aging       Date:  2013-03       Impact factor: 4.075

5.  The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults.

Authors:  Mi Kyung Lee; Sang Hui Chu; Duk Chul Lee; Ki Yong An; Ji-Hye Park; Dong Il Kim; Jiyoung Kim; Sunghyun Hong; Jee Aee Im; Ji Won Lee; Justin Y Jeon
Journal:  Clin Chim Acta       Date:  2013-02-26       Impact factor: 3.786

Review 6.  Effects of exercise on adipokines and the metabolic syndrome.

Authors:  Tongjian You; Barbara J Nicklas
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

7.  Adipocyte chemerin release is induced by insulin without being translated to higher levels in vivo.

Authors:  Sabrina Bauer; Margarita Bala; Andrea Kopp; Kristina Eisinger; Andreas Schmid; Sylvia Schneider; Markus Neumeier; Christa Buechler
Journal:  Eur J Clin Invest       Date:  2012-08-25       Impact factor: 4.686

8.  Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes.

Authors:  Michiko Takahashi; Yutaka Takahashi; Kenichi Takahashi; Fyodor N Zolotaryov; Kyoung Su Hong; Riko Kitazawa; Keiji Iida; Yasuhiko Okimura; Hidesuke Kaji; Sohei Kitazawa; Masato Kasuga; Kazuo Chihara
Journal:  FEBS Lett       Date:  2008-01-31       Impact factor: 4.124

9.  Twelve-week aerobic training decreases chemerin level and improves cardiometabolic risk factors in overweight and obese men.

Authors:  Abbas Saremi; Nader Shavandi; Mohammad Parastesh; Hassan Daneshmand
Journal:  Asian J Sports Med       Date:  2010-09

10.  Synthetic chemerin-derived peptides suppress inflammation through ChemR23.

Authors:  Jenna L Cash; Rosie Hart; Andreas Russ; John P C Dixon; William H Colledge; Joanne Doran; Alan G Hendrick; Mark B L Carlton; David R Greaves
Journal:  J Exp Med       Date:  2008-04-07       Impact factor: 14.307

View more
  5 in total

1.  A preliminary candidate approach identifies the combination of chemerin, fetuin-A, and fibroblast growth factors 19 and 21 as a potential biomarker panel of successful aging.

Authors:  Fabian Sanchis-Gomar; Helios Pareja-Galeano; Alejandro Santos-Lozano; Nuria Garatachea; Carmen Fiuza-Luces; Letizia Venturini; Giovanni Ricevuti; Alejandro Lucia; Enzo Emanuele
Journal:  Age (Dordr)       Date:  2015-04-25

2.  Semaphorin 3 C is a Novel Adipokine Representing Exercise-Induced Improvements of Metabolism in Metabolically Healthy Obese Young Males.

Authors:  Ji Sun Nam; Chul Woo Ahn; Hye Jun Park; Yu Sik Kim
Journal:  Sci Rep       Date:  2020-06-19       Impact factor: 4.379

3.  Aerobic exercise decreases chemerin/CMKLR1 in the serum and peripheral metabolic organs of obesity and diabetes rats by increasing PPARγ.

Authors:  Xiaojing Lin; Yanan Yang; Jing Qu; Xiaohui Wang
Journal:  Nutr Metab (Lond)       Date:  2019-03-05       Impact factor: 4.169

Review 4.  New insights into different adipokines in linking the pathophysiology of obesity and psoriasis.

Authors:  Yi Kong; Suhan Zhang; Ruifang Wu; Xin Su; Daoquan Peng; Ming Zhao; Yuwen Su
Journal:  Lipids Health Dis       Date:  2019-09-14       Impact factor: 4.315

Review 5.  Chemerin: A Potential Regulator of Inflammation and Metabolism for Chronic Obstructive Pulmonary Disease and Pulmonary Rehabilitation.

Authors:  Jian Li; Yufan Lu; Ning Li; Peijun Li; Zhengrong Wang; Wang Ting; Xiaodan Liu; Weibing Wu
Journal:  Biomed Res Int       Date:  2020-04-06       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.